These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Inhibition of the PD-1/PD-L1 signaling pathway enhances innate immune response of alveolar macrophages to mycobacterium tuberculosis in mice. Hu JF; Zhang W; Zuo W; Tan HQ; Bai W Pulm Pharmacol Ther; 2020 Feb; 60():101842. PubMed ID: 31541762 [TBL] [Abstract][Full Text] [Related]
68. Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Moliva JI; Turner J; Torrelles JB Front Immunol; 2017; 8():407. PubMed ID: 28424703 [No Abstract] [Full Text] [Related]
69. Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice. Koo MS; Manca C; Yang G; O'Brien P; Sung N; Tsenova L; Subbian S; Fallows D; Muller G; Ehrt S; Kaplan G PLoS One; 2011 Feb; 6(2):e17091. PubMed ID: 21364878 [TBL] [Abstract][Full Text] [Related]
70. The Host Response to a Clinical MDR Mycobacterial Strain Cultured in a Detergent-Free Environment: A Global Transcriptomics Approach. Leisching G; Pietersen RD; Mpongoshe V; van Heerden C; van Helden P; Wiid I; Baker B PLoS One; 2016; 11(4):e0153079. PubMed ID: 27055235 [TBL] [Abstract][Full Text] [Related]
71. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis. Abreu R; Giri P; Quinn F Front Immunol; 2020; 11():1553. PubMed ID: 32849525 [TBL] [Abstract][Full Text] [Related]
73. Beyond macrophages: the diversity of mononuclear cells in tuberculosis. Srivastava S; Ernst JD; Desvignes L Immunol Rev; 2014 Nov; 262(1):179-92. PubMed ID: 25319335 [TBL] [Abstract][Full Text] [Related]
74. Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia. Asalla S; Mohareer K; Banerjee S Front Cell Infect Microbiol; 2017; 7():439. PubMed ID: 29067283 [No Abstract] [Full Text] [Related]
75. Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Cardona PJ Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):7-14. PubMed ID: 20049645 [TBL] [Abstract][Full Text] [Related]
77. Multidimensional analysis of immune responses identified biomarkers of recent Mycobacterium tuberculosis infection. Lloyd T; Steigler P; Mpande CAM; Rozot V; Mosito B; Schreuder C; Reid TD; Hatherill M; Scriba TJ; Little F; Nemes E; PLoS Comput Biol; 2021 Jul; 17(7):e1009197. PubMed ID: 34319988 [TBL] [Abstract][Full Text] [Related]
78. CD157 Confers Host Resistance to Mycobacterium tuberculosis via TLR2-CD157-PKCzeta-Induced Reactive Oxygen Species Production. Yang Q; Liao M; Wang W; Zhang M; Chen Q; Guo J; Peng B; Huang J; Liu H; Yahagi A; Xu X; Ishihara K; Cooper A; Chen X; Cai Y mBio; 2019 Aug; 10(4):. PubMed ID: 31455656 [TBL] [Abstract][Full Text] [Related]
79. AmpliSeq transcriptome analysis of human alveolar and monocyte-derived macrophages over time in response to Mycobacterium tuberculosis infection. Papp AC; Azad AK; Pietrzak M; Williams A; Handelman SK; Igo RP; Stein CM; Hartmann K; Schlesinger LS; Sadee W PLoS One; 2018; 13(5):e0198221. PubMed ID: 29847580 [TBL] [Abstract][Full Text] [Related]
80. Establishment of a Patient-Derived, Magnetic Levitation-Based, Three-Dimensional Spheroid Granuloma Model for Human Tuberculosis. Kotze LA; Beltran CGG; Lang D; Loxton AG; Cooper S; Meiring M; Koegelenberg CFN; Allwood BW; Malherbe ST; Hiemstra AM; Glanzmann B; Kinnear C; Walzl G; du Plessis N mSphere; 2021 Aug; 6(4):e0055221. PubMed ID: 34287004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]